Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves

作者: Bernhard Wernly , Ann-Katrin Zappe , Axel Unbehaun , Jan-Malte Sinning , Christian Jung

DOI: 10.1007/S00392-018-1326-Z

关键词: Severity of illnessAortic valve stenosisInternal medicineStenosisSurvival rateAortic valveCardiologyValve replacementHemodynamicsRegurgitation (circulation)Medicine

摘要: We sought to investigate the procedural and hemodynamic outcome after valve-in-valve transcatheter aortic valve replacement (VinV-TAVR) for different surgical (SBV) (TAVR) bioprosthetic valves. 223 patients (76 ± 11years, STS-Score 8.3 ± 10.1) suffering from SBV failure treated with VinV-TAVR were enrolled at 6 centers across Germany. At time of intervention, majority in NYHA-class ≥ III (88%, n = 180). Failure mode SBVs was either stenosis, regurgitation (AR) or a combination both 85 (38%), 76 (34%) 62 (28%) patients, respectively. 138 (62%) first generation TAVR valves (Edwards Sapien XT CoreValve). Second implanted (38%) (Sapien 3, Medtronic CoreValve Evolut, SJM-Portico, JenaValve). associated high success rate, conversion surgery necessary 3 (2%) patients. After procedure, 4 suffered ≥ moderate AR. In (3%) second due mispositioning subsequent severe paravalvular Coronary obstruction observed Major bleeding cerebrovascular complications (according VARC) reported (1%) 30 days. Post-interventionally, 44/178 (25%) evidenced mean pressure gradient (mPG) ≥ 20 mmHg. Residual stenosis not increased mortality (HR 0.39; 95% CI 0.13–1.22; p = 0.11). SBV-failure is safe procedure resulting improvement common finding which can be 1/4 undergoing VinV-TAVR. However, this condition 1-year-mortality.

参考文章(50)
Philippe Pibarot, Neil J. Weissman, William J. Stewart, Rebecca T. Hahn, Brian R. Lindman, Thomas McAndrew, Susheel K. Kodali, Michael J. Mack, Vinod H. Thourani, D. Craig Miller, Lars G. Svensson, Howard C. Herrmann, Craig R. Smith, Josep Rodés-Cabau, John Webb, Scott Lim, Ke Xu, Irene Hueter, Pamela S. Douglas, Martin B. Leon, Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. Journal of the American College of Cardiology. ,vol. 64, pp. 1323- 1334 ,(2014) , 10.1016/J.JACC.2014.06.1195
Sergio Beltrame, Rafael Sadaba, John Trujillo, Stefano Urso, Beatriz Soriano, Lucia Piqueras, Gonzalo Aldamiz-Echevarria, Manuel Vives, Patient-prosthesis mismatch in elderly patients undergoing aortic valve replacement: impact on quality of life and survival. Journal of Heart Valve Disease. ,vol. 18, pp. 248- 255 ,(2009)
Jury Schewel, Dimitry Schewel, Christian Frerker, Peter Wohlmuth, Karl-Heinz Kuck, Ulrich Schäfer, Invasive hemodynamic assessments during transcatheter aortic valve implantation: comparison of patient outcomes in higher vs. lower transvalvular gradients with respect to left ventricular ejection fraction. Clinical Research in Cardiology. ,vol. 105, pp. 59- 71 ,(2016) , 10.1007/S00392-015-0889-1
Alexander Lauten, Adrian Laube, Harald Schubert, Sabine Bischoff, Sandor Nietzsche, Kim Horstkötter, Bhawana Poudel-Bochmann, Marcus Franz, Artur Lichtenberg, Hans R. Figulla, Payam Akhyari, Transcatheter treatment of tricuspid regurgitation by caval valve implantation--experimental evaluation of decellularized tissue valves in central venous position. Catheterization and Cardiovascular Interventions. ,vol. 85, pp. 150- 160 ,(2015) , 10.1002/CCD.25380
Ajay Yadlapati, Christopher Groh, S. Chris Malaisrie, Mark Gajjar, Jane Kruse, Sheridan Meyers, Rod Passman, Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves Clinical Research in Cardiology. ,vol. 105, pp. 268- 272 ,(2016) , 10.1007/S00392-015-0919-Z
M. B. Leon, N. Piazza, E. Nikolsky, E. H. Blackstone, D. E. Cutlip, A. P. Kappetein, M. W. Krucoff, M. Mack, R. Mehran, C. Miller, M.-a. Morel, J. Petersen, J. J. Popma, J. J. M. Takkenberg, A. Vahanian, G.-A. van Es, P. Vranckx, J. G. Webb, S. Windecker, P. W. Serruys, Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium European Heart Journal. ,vol. 32, pp. 205- 217 ,(2011) , 10.1093/EURHEARTJ/EHQ406
Alexander Lauten, Alexandra Gerhard-Garcia, Frank Suhr, Juergen H. Fischer, Hans R. Figulla, Wilhelm Bloch, Impact of Ischemia-Reperfusion on Extracellular Matrix Processing and Structure of the Basement Membrane of the Heart PLoS ONE. ,vol. 9, pp. e92833- ,(2014) , 10.1371/JOURNAL.PONE.0092833
Thomas Sénage, Thierry Le Tourneau, Yohann Foucher, Sabine Pattier, Caroline Cueff, Magali Michel, Jean-Michel Serfaty, Antoine Mugniot, Christian Périgaud, Hubert François Carton, Ousama Al Habash, Olivier Baron, Jean Christian Roussel, Early Structural Valve Deterioration of Mitroflow Aortic Bioprosthesis Mode, Incidence, and Impact on Outcome in a Large Cohort of Patients Circulation. ,vol. 130, pp. 2012- 2020 ,(2014) , 10.1161/CIRCULATIONAHA.114.010400
Michael Fritzenwanger, Christian Jung, Bjoern Goebel, Alexander Lauten, Hans R. Figulla, Impact of short-term systemic hypoxia on phagocytosis, cytokine production, and transcription factor activation in peripheral blood cells. Mediators of Inflammation. ,vol. 2011, pp. 429501- 429501 ,(2011) , 10.1155/2011/429501
Stuart J. Head, Mostafa M. Mokhles, Ruben L.J. Osnabrugge, Philippe Pibarot, Michael J. Mack, Johanna J.M. Takkenberg, Ad J.J.C. Bogers, Arie Pieter Kappetein, The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. European Heart Journal. ,vol. 33, pp. 1518- 1529 ,(2012) , 10.1093/EURHEARTJ/EHS003